HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 65 filers reported holding HERON THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $406,000 | +13.4% | 25,154 | -2.6% | 0.00% | +100.0% |
| Q2 2017 | $358,000 | +8.5% | 25,835 | +17.6% | 0.00% | 0.0% |
| Q1 2017 | $330,000 | +27.4% | 21,972 | +11.3% | 0.00% | 0.0% |
| Q4 2016 | $259,000 | -27.5% | 19,739 | -4.8% | 0.00% | 0.0% |
| Q3 2016 | $357,000 | -4.5% | 20,730 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $374,000 | +4.8% | 20,730 | +10.2% | 0.00% | 0.0% |
| Q1 2016 | $357,000 | -30.4% | 18,810 | -2.1% | 0.00% | 0.0% |
| Q4 2015 | $513,000 | +12.5% | 19,215 | +2.7% | 0.00% | 0.0% |
| Q3 2015 | $456,000 | -8.6% | 18,707 | +16.9% | 0.00% | 0.0% |
| Q2 2015 | $499,000 | +102.8% | 15,999 | -5.5% | 0.00% | +100.0% |
| Q1 2015 | $246,000 | +39.0% | 16,936 | -3.8% | 0.00% | 0.0% |
| Q4 2014 | $177,000 | +20.4% | 17,597 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $147,000 | -17.4% | 17,597 | +22.1% | 0.00% | 0.0% |
| Q2 2014 | $178,000 | – | 14,414 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |